Publications

Title

Author

Year

BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi.

Lalor, MK; FLOYD, S; GORAK-STOLINSKA, P; Ben-Smith, A; Weir, RE; SMITH, SG; Newport, MJ; BLITZ, R; Mvula, H; BRANSON, K; McGrath, N; CRAMPIN, AC; FINE, PE; DOCKRELL, HM;

2011

The Journal of infectious diseases, (2011).204 7 10.1093/infdis/jir515.

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.

ROCA, A; Hill, PC; Townend, J; Egere, U; ANTONIO, M; BOJANG, A; Akisanya, A; Litchfield, T; Nsekpong, DE; Oluwalana, C; Howie, SR C; GREENWOOD, B; Adegbola, RA;

2011

PLoS medicine, (2011).8 10 10.1371/journal.pmed.1001107.

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.

Ibarz-Pavón, AB; Maclennan, J; Andrews, NJ; Gray, SJ; Urwin, R; Clarke, SC; Walker, AM; Evans, MR; Kroll, JS; Neal, KR; Ala'aldeen, D; Crook, DW; Cann, K; Harrison, S; Cunningham, R; Baxter, D; Kaczmarski, E; McCarthy, ND; Jolley, KA; Cameron, JC; STUART, JM; Maiden, MC J;

2011

The Journal of infectious diseases, (2011).204 7 10.1093/infdis/jir466.

Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection.

SCOTT, JA G; OJAL, J; Ashton, L; Muhoro, A; Burbidge, P; Goldblatt, D;

2011

Clinical infectious diseases, (2011).53 7 10.1093/cid/cir444.

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.

ASANTE, KP; Abdulla, S; Agnandji, S; Lyimo, J; Vekemans, J; Soulanoudjingar, S; Owusu, R; Shomari, M; Leach, A; Jongert, E; Salim, N; Fernandes, JF; DOSOO, D; Chikawe, M; Issifou, S; Osei-Kwakye, K; Lievens, M; Paricek, M; Möller, T; Apanga, S; Mwangoka, G; Dubois, M-C; Madi, T; Kwara, E; Minja, R; ... Lell, B.

2011

The Lancet infectious diseases, (2011).11 10 10.1016/S1473-3099(11)70100-1.

Structural Basis for VRC01-Like-Antibody Recognition of Variable Loops that Surround the Site of CD4 Attachment on HIV-1 Gp120.

Zhou, T; Wu, X; Zhang, B; Moquin, S; Zhu, J; Georgiev, I; Bonsignori, M; Crump, JA; KAPIGA, SH; Noel, SE; Haynes, BF; Simek, M; Burton, DR; Koff, WC; Shapiro, L; Mascola, JR; Kwong, PD;

2011

AIDS RESEARCH AND HUMAN RETROVIRUSES, (2011).27 10

How does the level of BCG vaccine protection against tuberculosis fall over time?.

RODRIGUES, LC; MANGTANI, P; ABUBAKAR, I;

2011

BMJ (Clinical research ed), (2011).343 sep29 10.1136/bmj.d5974.

Development of vaccines against burkholderia pseudomallei.

Patel, N; CONEJERO, L; De Reynal, M; Easton, A; BANCROFT, GJ; Titball, RW;

2011

Frontiers in microbiology, (2011).2 SEP 10.3389/fmicb.2011.00198.

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.

JIT, M; Chapman, R; Hughes, O; Choi, YH;